Aberrant expression of chromogranin A, miR-146a, and miR-146b-5p in prostate structures with focally disrupted basal cell layers: an early sign of invasion and hormone-refractory cancer?
暂无分享,去创建一个
W. A. Gardner | A. Stojadinovic | W. Gardner | Y. Man | S. Fu | A Stojadinovic | M. Izadjoo | W A Gardner | Y G Man | S W Fu | A J Liu | M J Izadjoo | L Chen | L. Chen | A. Liu | S. Fu | Liang Chen
[1] N. Normanno,et al. Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV‐Cripto‐1 transgenic mice , 2004, Journal of cellular physiology.
[2] T. Boulikas,et al. Phosphorylation of transcription factors and control of the cell cycle. , 1995, Critical reviews in eukaryotic gene expression.
[3] N. Polissar,et al. Cancer-related changes in prostate DNA as men age and early identification of metastasis in primary prostate tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[4] Kenya Yamaguchi,et al. Implications of circulating chromogranin A in prostate cancer , 2007, Scandinavian journal of urology and nephrology.
[5] H. Bonkhoff,et al. Basement membranes in fetal, adult normal, hyperplastic and neoplastic human prostate , 2005, Virchows Archiv A.
[6] Donald C. Chang,et al. Loss of mir-146a function in hormone-refractory prostate cancer. , 2008, RNA.
[7] Ming Tan,et al. ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells. , 2006, Cancer research.
[8] Terence P. Speed,et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..
[9] B. Norlén,et al. Clinical Management of Premalignant Lesions of the Prostate , 2000, Scandinavian journal of urology and nephrology. Supplementum.
[10] T. Wheeler,et al. A cancer DNA phenotype in healthy prostates, conserved in tumors and adjacent normal cells, implies a relationship to carcinogenesis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[11] J. Fletcher,et al. Tumor suppressor genes in breast cancer: the gatekeepers and the caretakers. , 2005, American journal of clinical pathology.
[12] R Montironi,et al. p63 is a prostate basal cell marker and is required for prostate development. , 2000, The American journal of pathology.
[13] Y. Man,et al. Focal prostate basal cell layer disruptions and leukocyte infiltration are correlated events: A potential mechanism for basal cell layer disruptions and tumor invasion. , 2005, Cancer detection and prevention.
[14] M. Webber,et al. Prostate-specific antigen, a serine protease, facilitates human prostate cancer cell invasion. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[15] K. Żukowski,et al. Degradation of basement membrane by prostate tumor heparanase. , 1999, The Journal of surgical research.
[16] W. A. Gardner,et al. Atrophy and proliferation in the young adult prostate. , 1987, The Journal of urology.
[17] S. Artavanis-Tsakonas,et al. Notch: the past, the present, and the future. , 2010, Current topics in developmental biology.
[18] Rafael A Irizarry,et al. Processing of Agilent microRNA array data , 2010, BMC Research Notes.
[19] A. Verstraeten,et al. Tenascin expression in basal cell carcinoma , 1992, The British journal of dermatology.
[20] N. Goldstein,et al. Cytokeratin 34βE-12 immunoreactivity in benign prostatic acini : Quantitation, pattern assessment, and electron microscopic study , 1999 .
[21] G P Siegal,et al. Loss of basement membrane components by invasive tumors but not by their benign counterparts. , 1983, Laboratory investigation; a journal of technical methods and pathology.
[22] M. Cerruto,et al. The possible role of chromogranin A as a prognostic factor in organ-confined prostate cancer. , 2005, The International journal of biological markers.
[23] Wei Zhang,et al. A functional polymorphism in Pre‐miR‐146a gene is associated with prostate cancer risk and mature miR‐146a expression in vivo , 2010, The Prostate.
[24] F. Abbas,et al. Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer , 2008, BMC urology.
[25] W. A. Gardner,et al. Embryonal hyperplasia of the prostate , 1986 .
[26] J. Hoying,et al. HER2/neu over‐expression induces endothelial cell retraction , 2001, International journal of cancer.
[27] M. Villaronga,et al. Notch signaling: a potential therapeutic target in prostate cancer. , 2008, Current cancer drug targets.
[28] T. Boulikas. Control of DNA replication by protein phosphorylation. , 1994, Anticancer research.
[29] Chengquan Zhao,et al. A subset of prostate basal cells lacks the expression of corresponding phenotypic markers. , 2006, Pathology, research and practice.
[30] Y. Doki,et al. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy , 2009, Cancer.
[31] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[32] Yusuke Nakamura,et al. Molecular Features of the Transition from Prostatic Intraepithelial Neoplasia (PIN) to Prostate Cancer , 2004, Cancer Research.
[33] M. Webber,et al. Intercellular Communication and Human Prostate Carcinogenesis , 2002, Annals of the New York Academy of Sciences.
[34] Z. Qu. Immunohistological detection of growth factors and cytokines in tissue mast cells. , 2006, Methods in molecular biology.
[35] A. Mills,et al. Role of p63 and basal cells in the prostate , 2004, Development.
[36] D. Bostwick. Prostatic intraepithelial neoplasia is a risk factor for cancer. , 1999, Seminars in urologic oncology.
[37] J. O’Sullivan,et al. Tumor Budding is a Strong and Reproducible Prognostic Marker in T3N0 Colorectal Cancer , 2009, The American journal of surgical pathology.
[38] J. Oesterling,et al. The Relationship Between Prostatic Intraepithelial Neoplasia and Prostate Cancer: Critical Issues , 1997 .
[39] W. A. Gardner,et al. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion. , 2008, Medical hypotheses.
[40] S. Tretli,et al. Is prostatic intraepithelial neoplasia in the transition/central zone a true precursor of cancer? A long-term retrospective study in Norway. , 1998, British Journal of Cancer.
[41] K. Tsubota,et al. Tryptase increases proliferative activity of human conjunctival fibroblasts through protease-activated receptor-2. , 2005, Investigative ophthalmology & visual science.
[42] Y. Nishiwaki,et al. Histopathologic Features of the Tumor Budding in Adenocarcinoma of the Lung: Tumor Budding As an Index to Predict the Potential Aggressiveness , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[43] W. Eckhart,et al. Type I insulin-like growth factor receptor over-expression induces proliferation and anti-apoptotic signaling in a three-dimensional culture model of breast epithelial cells , 2006, Breast Cancer Research.
[44] W. Isaacs,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Pathological and Molecular Aspects of Prostate Cancer Prostate Cancer Ii , 2022 .
[45] H. Bonkhoff,et al. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: A stem cell model , 1996, The Prostate.
[46] L. Holmberg,et al. Tumour markers in breast carcinoma correlate with grade rather than with invasiveness , 2001, British Journal of Cancer.
[47] Jerome P. Richie,et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. , 1998, JAMA.
[48] S. Sheng,et al. Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[49] Wei Zhang,et al. Maspin expression profile in human prostate cancer (CaP) and in vitro induction of Maspin expression by androgen ablation. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[50] Nadine Kabbani,et al. Enhanced Proliferation, Survival, and Dopaminergic Differentiation of CNS Precursors in Lowered Oxygen , 2000, The Journal of Neuroscience.
[51] L. Qi,et al. Neuroendocrine differentiation is involved in chemoresistance induced by EGF in prostate cancer cells. , 2009, Life sciences.
[52] Liang Chen,et al. miRNA Biomarkers in Breast Cancer Detection and Management , 2011, Journal of Cancer.
[53] M. Chopp,et al. MiR-146b-5p Suppresses EGFR Expression and Reduces In Vitro Migration and Invasion of Glioma , 2010, Cancer investigation.
[54] K. Hellström,et al. Development of a cancer DNA phenotype prior to tumor formation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[55] Brian Leyland-Jones,et al. Optimization of RNA extraction from FFPE tissues for expression profiling in the DASL assay. , 2008, BioTechniques.
[56] T. Roskams,et al. Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer? , 2003, Prostate Cancer and Prostatic Diseases.
[57] H. Bonkhoff. Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[58] T. Golde,et al. Targeting Notch to Target Cancer Stem Cells , 2010, Clinical Cancer Research.
[59] M. Papotti,et al. Chromogranin A expression in patients with hormone naïve prostate cancer predicts the development of hormone refractory disease. , 2007, The Journal of urology.
[60] John C. Doyle,et al. Oxygen‐mediated regulation of skeletal muscle satellite cell proliferation and adipogenesis in culture , 2001, Journal of cellular physiology.
[61] A. El-Karef,et al. Co‐stimulation of human breast cancer cells with transforming growth factor‐β and tenascin‐C enhances matrix metalloproteinase‐9 expression and cancer cell invasion , 2004, International journal of experimental pathology.
[62] Takashi Sato,et al. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases. , 2004, Gynecologic oncology.
[63] E. Jarocka-Cyrta,et al. Mast cells in neoangiogenesis. , 2006, Medical science monitor : international medical journal of experimental and clinical research.
[64] L. Dogliotti,et al. Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease. , 2005, Endocrine-related cancer.
[65] R. Autorino,et al. Neuroendocrine Immunophenotype as Predictor of Clinical Recurrence in 110 Patients with Prostate Cancer , 2007, International journal of immunopathology and pharmacology.
[66] Y. Man,et al. An antigen unmasking protocol that satisfies both immunohistochemistry and subsequent PCR amplification. , 2003, Pathology, research and practice.
[67] F. Booth,et al. Culture in low levels of oxygen enhances in vitro proliferation potential of satellite cells from old skeletal muscles , 2001, Cellular and Molecular Life Sciences (CMLS).
[68] Donald C. Malins,et al. A new structural analysis of DNA using statistical models of infrared spectra , 1997, Nature Medicine.
[69] H. Bonkhoff,et al. Morphogenese der benignen Prostatahyperplasie und des Prostatakarzinoms , 1998, Der Pathologe.
[70] C. Stephan,et al. MicroRNAs as regulators of signal transduction in urological tumors. , 2011, Clinical chemistry.
[71] Roger J Daly,et al. Increased Proliferation and Altered Growth Factor Dependence of Human Mammary Epithelial Cells Overexpressing the Gab2 Docking Protein* , 2006, Journal of Biological Chemistry.
[72] R. Nakamura. Cancer diagnostics : current and future trends , 2004 .
[73] L. Ellis,et al. Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. , 1996, Journal of the National Cancer Institute.
[74] D. Bostwick. Prospective origins of prostate carcinoma: Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia , 1996, Cancer.
[75] K. Leong,et al. The Notch pathway in prostate development and cancer. , 2008, Differentiation; research in biological diversity.